Innophos (IPHS) Rating Lowered to C+ at TheStreet

Share on StockTwits

TheStreet cut shares of Innophos (NASDAQ:IPHS) from a b- rating to a c+ rating in a research note published on Thursday morning, TheStreetRatingsTable reports.

Several other research firms also recently issued reports on IPHS. BidaskClub downgraded Innophos from a hold rating to a sell rating in a report on Monday, May 20th. Zacks Investment Research upgraded Innophos from a sell rating to a hold rating in a report on Tuesday, April 30th. ValuEngine upgraded Innophos from a strong sell rating to a sell rating in a report on Monday, February 4th. Finally, Seaport Global Securities assumed coverage on Innophos in a report on Thursday, February 21st. They set a buy rating on the stock. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and one has issued a buy rating to the company. The stock presently has a consensus rating of Hold.

IPHS stock opened at $27.61 on Thursday. The company has a current ratio of 3.14, a quick ratio of 1.49 and a debt-to-equity ratio of 0.95. The firm has a market capitalization of $543.09 million, a P/E ratio of 12.11 and a beta of 1.33. Innophos has a 12-month low of $22.57 and a 12-month high of $50.40.

Innophos (NASDAQ:IPHS) last posted its quarterly earnings data on Tuesday, April 30th. The specialty chemicals company reported $0.57 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.43 by $0.14. The firm had revenue of $191.41 million for the quarter, compared to the consensus estimate of $199.90 million. Innophos had a return on equity of 13.09% and a net margin of 4.30%. The company’s quarterly revenue was down 6.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.61 EPS. On average, research analysts expect that Innophos will post 2.36 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, June 7th. Shareholders of record on Friday, May 17th will be issued a dividend of $0.48 per share. The ex-dividend date of this dividend is Thursday, May 16th. This represents a $1.92 annualized dividend and a yield of 6.95%. Innophos’s dividend payout ratio (DPR) is 84.21%.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Public Employees Retirement System of Ohio increased its holdings in Innophos by 14.1% during the 4th quarter. Public Employees Retirement System of Ohio now owns 2,708 shares of the specialty chemicals company’s stock worth $66,000 after purchasing an additional 334 shares during the period. Rhumbline Advisers increased its holdings in Innophos by 0.6% during the 1st quarter. Rhumbline Advisers now owns 58,275 shares of the specialty chemicals company’s stock worth $1,756,000 after purchasing an additional 342 shares during the period. Great West Life Assurance Co. Can increased its holdings in Innophos by 1.4% during the 4th quarter. Great West Life Assurance Co. Can now owns 26,640 shares of the specialty chemicals company’s stock worth $603,000 after purchasing an additional 364 shares during the period. Comerica Bank increased its holdings in Innophos by 2.5% during the 1st quarter. Comerica Bank now owns 19,410 shares of the specialty chemicals company’s stock worth $626,000 after purchasing an additional 471 shares during the period. Finally, Texas Permanent School Fund increased its holdings in Innophos by 3.7% during the 1st quarter. Texas Permanent School Fund now owns 13,316 shares of the specialty chemicals company’s stock worth $401,000 after purchasing an additional 480 shares during the period. Institutional investors own 93.29% of the company’s stock.

Innophos Company Profile

Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.

Recommended Story: Why are gap-down stocks important?

Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

$603.70 Million in Sales Expected for ConturaEnergyInc   .  This Quarter
$603.70 Million in Sales Expected for ConturaEnergyInc . This Quarter
Analysts Anticipate Verisign, Inc.  Will Post Quarterly Sales of $306.45 Million
Analysts Anticipate Verisign, Inc. Will Post Quarterly Sales of $306.45 Million
J2 Global Inc  Expected to Post Quarterly Sales of $318.47 Million
J2 Global Inc Expected to Post Quarterly Sales of $318.47 Million
$2.69 Billion in Sales Expected for Iqvia Holdings Inc  This Quarter
$2.69 Billion in Sales Expected for Iqvia Holdings Inc This Quarter
Zacks: Analysts Anticipate CarMax, Inc  Will Announce Quarterly Sales of $5.22 Billion
Zacks: Analysts Anticipate CarMax, Inc Will Announce Quarterly Sales of $5.22 Billion
Zacks: Analysts Anticipate Papa John’s Int’l, Inc.  Will Post Quarterly Sales of $396.88 Million
Zacks: Analysts Anticipate Papa John’s Int’l, Inc. Will Post Quarterly Sales of $396.88 Million


© 2006-2019 Ticker Report